Exact Mass: 517.1705036000001
Exact Mass Matches: 517.1705036000001
Found 199 metabolites which its exact mass value is equals to given mass value 517.1705036000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Piperacillin
Piperacillin is only found in individuals that have used or taken this drug. It is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic proposed for pseudomonas infections. It is also used in combination with other antibiotics. [PubChem]By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Piperacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Piperacillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams Acquisition and generation of the data is financially supported in part by CREST/JST. C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Same as: D08380 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Piperacillin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Same as: D08380 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS KEIO_ID P039
N2,N7-dicyclohexyl-9-(hydroxyimino)-9H-fluorene-2,7-disulfonamide
C25H31N3O5S2 (517.1705036000001)
Neoacrimarine J
Neoacrimarine J is found in citrus. Neoacrimarine J is an alkaloid from the roots of Citrus paradisi (grapefruit Alkaloid from the roots of Citrus paradisi (grapefruit). Neoacrimarine J is found in citrus.
Vitisin B
Vitisin B is found in alcoholic beverages. Vitisin B is a constituent of some red wines.
Pyroglu-Glu-Asp-Ser-GlyOH
C19H27N5O12 (517.1656141999999)
3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid
methyl (2S)-6-[(beta-D-glucopyranosyl)oxy]-2,3-dihydro-5-hydroxy-1-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]-1H-indole-2-carboxylate|oleracein G
C25H27NO11 (517.1584032000001)
Cys Cys His Arg
Cys Cys Arg His
Cys His Cys Arg
Cys His Lys Met
Cys His Met Lys
Cys His Met Gln
C19H31N7O6S2 (517.1777146000001)
Cys His Gln Met
C19H31N7O6S2 (517.1777146000001)
Cys His Arg Cys
Cys Lys His Met
Cys Lys Met His
Cys Met His Lys
Cys Met His Gln
C19H31N7O6S2 (517.1777146000001)
Cys Met Lys His
Cys Met Gln His
C19H31N7O6S2 (517.1777146000001)
Cys Gln His Met
C19H31N7O6S2 (517.1777146000001)
Cys Gln Met His
C19H31N7O6S2 (517.1777146000001)
Cys Arg Cys His
Cys Arg His Cys
Asp Pro Thr Trp
Asp Pro Trp Thr
Asp Gln Gln Gln
Asp Thr Pro Trp
Asp Thr Trp Pro
Asp Trp Pro Thr
Asp Trp Thr Pro
Glu Asn Gln Gln
Glu Pro Ser Trp
Glu Pro Trp Ser
Glu Gln Asn Gln
Glu Gln Gln Asn
Glu Ser Pro Trp
Glu Ser Trp Pro
Glu Trp Pro Ser
Glu Trp Ser Pro
Naltrexone-3-glucuronide
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids
His Cys Cys Arg
His Cys Lys Met
His Cys Met Lys
His Cys Met Gln
C19H31N7O6S2 (517.1777146000001)
His Cys Gln Met
C19H31N7O6S2 (517.1777146000001)
His Cys Arg Cys
His Lys Cys Met
His Lys Met Cys
His Met Cys Lys
His Met Cys Gln
C19H31N7O6S2 (517.1777146000001)
His Met Lys Cys
His Met Gln Cys
C19H31N7O6S2 (517.1777146000001)
His Gln Cys Met
C19H31N7O6S2 (517.1777146000001)
His Gln Met Cys
C19H31N7O6S2 (517.1777146000001)
His Arg Cys Cys
Lys Cys His Met
Lys Cys Met His
Lys His Cys Met
Lys His Met Cys
Lys Met Cys His
Lys Met His Cys
Met Cys His Lys
Met Cys His Gln
C19H31N7O6S2 (517.1777146000001)
Met Cys Lys His
Met Cys Gln His
C19H31N7O6S2 (517.1777146000001)
Met His Cys Lys
Met His Cys Gln
C19H31N7O6S2 (517.1777146000001)
Met His Lys Cys
Met His Gln Cys
C19H31N7O6S2 (517.1777146000001)
Met Lys Cys His
Met Lys His Cys
Met Gln Cys His
C19H31N7O6S2 (517.1777146000001)
Met Gln His Cys
C19H31N7O6S2 (517.1777146000001)
Asn Glu Gln Gln
Asn Gln Glu Gln
Asn Gln Gln Glu
Pro Asp Thr Trp
Pro Asp Trp Thr
Pro Glu Ser Trp
Pro Glu Trp Ser
Pro Ser Glu Trp
Pro Ser Trp Glu
Pro Thr Asp Trp
Pro Thr Trp Asp
Pro Trp Asp Thr
Pro Trp Glu Ser
Pro Trp Ser Glu
Pro Trp Thr Asp
Gln Cys His Met
C19H31N7O6S2 (517.1777146000001)
Gln Cys Met His
C19H31N7O6S2 (517.1777146000001)
Gln Asp Gln Gln
Gln Glu Asn Gln
Gln Glu Gln Asn
Gln His Cys Met
C19H31N7O6S2 (517.1777146000001)
Gln His Met Cys
C19H31N7O6S2 (517.1777146000001)
Gln Met Cys His
C19H31N7O6S2 (517.1777146000001)
Gln Met His Cys
C19H31N7O6S2 (517.1777146000001)
Gln Asn Glu Gln
Gln Asn Gln Glu
Gln Gln Asp Gln
Gln Gln Glu Asn
Gln Gln Asn Glu
Gln Gln Gln Asp
Arg Cys Cys His
Arg Cys His Cys
Arg His Cys Cys
Ser Glu Pro Trp
Ser Glu Trp Pro
Ser Pro Glu Trp
Ser Pro Trp Glu
Ser Trp Glu Pro
Ser Trp Pro Glu
Thr Asp Pro Trp
Thr Asp Trp Pro
Thr Pro Asp Trp
Thr Pro Trp Asp
Thr Trp Asp Pro
Thr Trp Pro Asp
Trp Asp Pro Thr
Trp Asp Thr Pro
Trp Glu Pro Ser
Trp Glu Ser Pro
Trp Pro Asp Thr
Trp Pro Glu Ser
Trp Pro Ser Glu
Trp Pro Thr Asp
Trp Ser Glu Pro
Trp Ser Pro Glu
Trp Thr Asp Pro
Trp Thr Pro Asp
Neoacrimarine J
Vitisin B
2-Methyl-2-propanyl 4-(6-{[5-bromo-4-(cyclopentylamino)-2-pyrimid inyl]amino}-3-pyridinyl)-1-piperazinecarboxylate
9,10-Dihydro-9,10-bis(2-carboxyethyl)-N-(4-nitrophenyl)-10,9-(epoxyimino)anthracene-12-carboxamide
C27H23N3O8 (517.1485078000001)
Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine
Stallimycin hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D004214 - Distamycins D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
DISODIUM FOLINATE
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment
Agerafenib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2336 - Raf Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Agerafenib (CEP-32496; RXDX-105) is a highly potent and orally efficacious inhibitor of BRAFV600E with a Kd of 14 nM.
Fosbretabulin tromethamine
C22H32NO11P (517.1712891999999)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
3-(5-(4-(Cyclopentyloxy)-2-hydroxybenzoyl)-2-((3-hydroxybenzo[d]isoxazol-6-yl)methoxy)phenyl)propanoic acid
2-[Bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester
N(5)-[amino(sulfoamino)phosphoryl]-L-ornithyl-L-alanyl-L-arginine
(2S)-2-[[(2S)-2-[[(2S)-5-[[amino-(sulfonatoamino)phosphoryl]amino]-2-azaniumylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneazaniumyl)pentanoate
[3-(4-Hydroxy-3,5-dimethoxyphenyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-ylidene]oxidanium
8-[4-(4-Fluorophenoxy)-3-nitrophenyl]-7-(2-hydroxyethyl)-3-(phenylmethyl)purine-2,6-dione
C26H20FN5O6 (517.1397552000001)
1-[[(4R,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-cyclopentyl-1-methylurea
1-[[(4S,5S)-8-bromo-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-cyclopentyl-1-methylurea
3,6-diamino-10-(4-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-4-oxobutyl)acridinium perchlorate
(3R,3R,4S,5R)-7-bromo-5-(2-hydroxyethyl)-4-[(4-methoxyphenyl)-dimethylsilyl]-1,3,5-trimethyl-2-spiro[indole-3,2-oxolane]one
4-(5-carboxypentyl)-N-[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl]-L-phenylalanine
C26H28ClNO8 (517.1503358000001)
[(1S,2S)-cyclohexane-1,2-diamine-kappa(2)N,N](5,6-dimethyl-1,10-phenanthroline-kappa(2)N(1),N(10))platinum(2+)
[(1R)-7-methoxy-2-(4-methylphenyl)sulfonyl-1-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C29H31N3O4S (517.2035166000001)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-2-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-3-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
[(1R)-7-methoxy-1-(4-methylphenyl)sulfonyl-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C29H31N3O4S (517.2035166000001)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
[(1S)-7-methoxy-2-(4-methylphenyl)sulfonyl-1-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C29H31N3O4S (517.2035166000001)
[(1S)-7-methoxy-1-(4-methylphenyl)sulfonyl-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C29H31N3O4S (517.2035166000001)
(3-aminopropyl)(L-aspartyl-1-amino)phosphoryl-5-adenosine(1-)
(2S,5S,6R)-6-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)-oxomethyl]amino]-1-oxo-2-phenylethyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2E)-3-ethyl-2-[(E)-3-(3-ethyl-4,5-diphenyl-1,3-thiazol-3-ium-2-yl)prop-2-enylidene]benzo[g][1,3]benzothiazole
Phaseolotoxin
A tripeptide resulting from the formal condensation of the carboxy group of N(5)-[amino(sulfoamino)phosphoryl]-L-ornithine with the N-terminal amino group of L-alanyl-L-arginine. A toxin produced by cultured Pseudomonas syringae, the causal agent of halo blight disease in bean plants.
(-)-GSK598809 (hydrochloride)
(-)-GSK598809 is an isomer of GSK598809. GSK598809 is a potent and selective dopamine D3 Receptor (DRD3) antagonist. (-)-GSK598809 is an isomer of GSK598809. GSK598809 is a potent and selective dopamine D3 Receptor (DRD3) antagonist.
AZD3147
AZD3147 is a potent, orally active, selective dual inhibitor of mTORC1 and mTORC2 with an IC50 value of 1.5 nM. AZD3147 also has a selective effect on PI3K[1]. AZD3147 is a potent, orally active, selective dual inhibitor of mTORC1 and mTORC2 with an IC50 value of 1.5 nM. AZD3147 also has a selective effect on PI3K[1].